Evidence map›Paper›PMID 31166194›Full record

ReviewCurrent issues in molecular biology2019

Specialized Metabolites from Methylotrophic Proteobacteria.

Aaron W Puri

Abstract readReview
In one paragraph

Review in Current issues in molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Establishment of anmSystems · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. AntarcticFrontiers in microbiology · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Aaron W PuriDepartment of Chemical Engineering, University of Washington, Seattle, WA, USA.

Funding

Methane-oxidizing bacterial communities: A novel source of bioactive chemical diversityR00GM118762 · NIGMS · UNIVERSITY OF UTAH · PI PURI, AARON WEBSTER · 2019 to 2021
$743k
Methane-Oxidizing Bacterial Communities: A Novel Source Of Bioactive Chemical DiversityK99GM118762 · NIGMS · UNIVERSITY OF WASHINGTON · PI PURI, AARON WEBSTER · 2016 to 2017
$161k
NIGMS NIH HHS K99 GM118762NIGMS NIH HHS R00 GM118762
6 · The paper itself

Abstract

Biosynthesized small molecules known as specialized metabolites often have valuable applications in fields such as medicine and agriculture. Consequently, there is always a demand for novel specialized metabolites and an understanding of their bioactivity. Methylotrophs are an underexplored metabolic group of bacteria that have several growth features that make them enticing in terms of specialized metabolite discovery, characterization, and production from cheap feedstocks such as methanol and methane gas. This chapter will examine the predicted biosynthetic potential of these organisms and review some of the specialized metabolites they produce that have been characterized so far.

Indexed as

AgricultureBiological ProductsBiomedical TechnologyMedicineMetabolic EngineeringMetabolic Networks and PathwaysMethaneMethanolProteobacteriaSpecies SpecificityBiological ProductsMethaneMethanol

Identifiers

PMID31166194
PMCPMC8518990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.